ビタミン
Online ISSN : 2424-080X
Print ISSN : 0006-386X
心身障害児にたいするホモパントテン酸の治療効果の検討
寺脇 保平山 清武今村 正人永田 良隆川畑 真吾
著者情報
ジャーナル フリー

1967 年 36 巻 2 号 p. 150-175

詳細
抄録
It has been reported that homopantothenic acid (HOPA) which is obtained by the substitution of β-alanine group of pantothenic acid for γ-aminobutyric acid can easily pass through the blood brain barrier and exerts good effects on diseases of the brain. In the present clinical trial of HOPA therapy for 26 retarded children, it was also demonstrated that the electroence-phalogram was apparently improved and intelligence quotient was increased higher in HOPA-treated group than in the control group when tested "Analytical developmental examination method", designed by Enjoji.
著者関連情報
© 1967 日本ビタミン学会

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 改変禁止 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
前の記事 次の記事
feedback
Top